Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2019-01-14 2018-10-23
Drug Identification Number 02225964 02225964
Brand name TEMAZEPAM TEMAZEPAM
Common or Proper name TEMAZEPAM TEMAZEPAM
Company Name APOTEX INC APOTEX INC
Ingredients TEMAZEPAM TEMAZEPAM
Strength(s) 15MG 15MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N05CD N05CD
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-11-22 2018-11-23
Actual discontinuation date 2018-11-22
Remaining supply date 2018-11-22 2018-11-23
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments